Eurazeo, Partners Group in Aroma-Zone Deal Talks

Eurazeo is in exclusive negotiations to divest its stake in Aroma-Zone, a prominent player in the natural beauty and wellness sector. The proposed transaction sees Partners Group emerging as the likely majority stakeholder, acquiring the interest from Eurazeo's Capital IV fund. This move signals a significant shift for the French direct-to-consumer brand, which has experienced substantial growth since Eurazeo's initial investment in 2021.

The deal, valued at approximately €576 million for Eurazeo's balance sheet, includes a crucial reinvestment component. Eurazeo's Capital V fund intends to participate alongside Partners Group, underscoring a continued belief in Aroma-Zone's long-term trajectory. This dual approach allows Eurazeo to realize capital gains while maintaining exposure to the company's future expansion, a strategy often employed to leverage successful portfolio company performance.

Founded in 1999 by the Vausselin family, Aroma-Zone has carved out a unique niche by emphasizing efficacy, safety, and accessibility in its product offerings. The company has cultivated a loyal customer base exceeding five million individuals, bolstered by a dedicated workforce. Under the leadership of CEO Sabrina Herlory-Rouget, Aroma-Zone has significantly enhanced its omnichannel capabilities, streamlined operations, and invested heavily in digital infrastructure, supply chain, and human capital. This strategic focus has been instrumental in its recent growth phase.

Since 2021, Aroma-Zone has more than tripled its revenue, a testament to its robust business model and effective market penetration. The company has also expanded its international presence, establishing footholds in markets such as Belgium, Italy, and the United Kingdom. This expansion, coupled with strong customer engagement metrics, positions Aroma-Zone as an attractive asset in the rapidly growing global wellness and clean beauty market, a sector projected to reach hundreds of billions in value over the next decade.

Amandine Ayrem, Partner at Eurazeo, highlighted the firm's initial vision for Aroma-Zone as a category-defining entity at the nexus of natural beauty, wellness, and preventive health. She emphasized the brand's authenticity, trust-based model, and the successful scaling achieved during Eurazeo's stewardship. The proposed transaction, Ayrem noted, would enable Eurazeo to crystallize value while reaffirming its commitment through a substantial reinvestment.

The transaction remains contingent on standard regulatory approvals, including consultation with employee representatives and antitrust clearance. The involvement of Partners Group, a global private equity firm with extensive experience in consumer and healthcare sectors, is expected to provide Aroma-Zone with the resources and strategic guidance necessary to pursue its next phase of innovation and international growth.